跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AS-1411
首页
药物
AS-1411
AS-1411
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
GUANOSINE-RICH OLIGONUCLEOTIDE (GRO) COMPOSITIONS, METHODS AND USES FOR TREATING RESPIRATORY SYNCYTIAL VIRUS INFECTION
US 2015010618 A1
申请人: UNIV TORONTO
优先权: 2013
CN
US
3 件公开
Antibiotic 97518, pharmaceutically acceptable salts and compositions, and use thereof
EP 1481986 A1
申请人: VICURON PHARM INC
优先权: 2003
EP
Application of PSFL-1411 in preparation of medicine for treating refractory chronic cough
CN 119367360 A
申请人: HANGZHOU BADI PHARMACEUTICAL TECH CO LTD
优先权: 2023
CN
Rapid Onset Therapeutic Anti-Depression Ketosis Enabled by D-BetaHydroxyButyric Acid Systems, Methods and Compounds for Psilocybin co-administration
US 2024216310 A1
申请人: AMERICAN KETONE THERAPEUTICS LLC
优先权: 2023
US
Rapid Onset Therapeutic Ketosis Enabled by D-BetaHydroxyButyric Acid Systems, Compounds and Methods for Stroke medication co-administration
US 2024269095 A1
申请人: AMERICAN KETONE THERAPEUTICS LLC
优先权: 2023
US
Rapid Onset Therapeutic Ketosis Enabled by D-BetaHydroxyButyric Acid Systems, Compounds and Methods for Sepsis Protection and Enhanced Medical Recovery
US 2024269096 A1
申请人: AMERICAN KETONE THERAPEUTICS LLC
优先权: 2023
US
药物
反馈